Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials
about
Current best practice in the management of hypertensive disorders in pregnancyLow-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-AnalysisA Dormant Microbial Component in the Development of PreeclampsiaPreventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians:A systematic review and meta-analysis.Hematologic complications of pregnancy.A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) studyAssociations between maternal risk factors of adverse pregnancy and birth outcomes and the offspring epigenetic clock of gestational age at birth"Platelet-associated regulatory system (PARS)" with particular reference to female reproductionAdvances in the pathophysiology of pre-eclampsia and related podocyte injury.Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?Maternal Prenatal Positive Affect, Depressive and Anxiety Symptoms and Birth Outcomes: The PREDO Study.First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudyPerspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study.Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study.Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.Punicalagin, a polyphenol in pomegranate juice, downregulates p53 and attenuates hypoxia-induced apoptosis in cultured human placental syncytiotrophoblasts.Aspirin for prevention of preeclampsia in lupus pregnancy.Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications.New directions in the prediction of pre-eclampsia.Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.Pre-eclampsia part 2: prediction, prevention and management.Pregnancy and cardiovascular risk for women with Turner syndrome.Aspirin and heparin in pregnancy.Potential role of folate in pre-eclampsia.Potential targets for the treatment of preeclampsia.Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.Aspirin vs Heparin for the Prevention of Preeclampsia.Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.Ambulatory blood pressure measurements in mid-pregnancy and development of hypertensive pregnancy disorders.Maternal Serum Aneuploidy Screen and Adverse Pregnancy OutcomesAspirin for Prevention of Preeclampsia.Aspirin in the prevention of pre-eclampsia in high-risk women.Aspirin for pre-eclampsia: beware of subgroup meta-analysis.Statins in pregnancy: safety and perspectives of therapeutic applications.Initiation of aspirin in early gestation for the prevention of pre-eclampsia.Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe.Optimal first trimester preeclampsia prediction: a comparison of multimarker algorithm, risk profiles and their sequential application.Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
P2860
Q26739585-5A9BC1F8-0070-44DC-B966-6408F4B4CB7AQ26824714-1CAB26EC-2C89-4AF4-BCBF-46B95048C8CAQ28069689-620B1838-0AC4-4455-9AA3-65381278C292Q30249543-B59F1D80-1EE3-407E-B283-49C5B9DBC073Q33409852-C7AC807F-CE3E-499B-8730-08DB92B03050Q33634772-D6F38736-3000-4746-A042-72A5C691C15BQ33651669-C7BC90E7-43EB-476C-89B6-88A8FA000CB8Q33690681-FA79E5E5-AA27-4369-9A8D-311A5829D4D5Q33983807-ABE12F24-3C22-471B-B3D6-6BFEB72D9C43Q34714619-72775CD9-B2C0-42B9-B6A6-321A004872CBQ35161111-362D2D54-B1A5-462B-9B7E-94AF6B63D047Q35937206-F19B26DB-32D6-42EC-AAA9-C87A2FCC91D9Q36184116-5DCF0CB2-A778-4F1D-9DF0-F9C9B856CDD8Q36243237-FB2AB891-C4E3-423B-80FF-D3A1A9D58948Q36325415-9483AB91-D46C-4559-80CE-C66AA5C023B6Q36819758-011754C2-F02C-4F38-B94C-3CDB5879F3B9Q37341983-D965891F-93E7-4946-B72A-3F81734D9587Q37687986-E577E773-4591-4797-8210-65D3BD8787CEQ37699576-B377A11E-9E68-455A-818F-8D9E79EC29F0Q38172962-1315CEAA-D219-4300-8CDB-B736C8559E76Q38209622-EB9D34C1-2B47-47DC-BB18-55B2019C515CQ38227251-4F97C134-8C49-4880-A18A-EB6D685BB344Q38254655-43046193-31E3-4E17-A5D4-7FB18DA0A463Q38544097-6B85F930-096B-49BB-BAE4-76293BB8FCB5Q38584627-6CC0B064-60D6-4E02-B0FE-E993F50689CFQ38590180-FCD40A7A-17E7-48EE-9D87-DCFCAC30750AQ38689590-FB4B5557-C39E-495D-AB25-A25B0CA06905Q38824646-0D6D3AD3-5A3D-49B6-B18B-17BB25A8FBF4Q38850828-98EFD83E-920E-4CAA-AEAC-813CFF1C0A82Q39013953-5D47F545-465D-46FB-81CA-7C935DC16930Q39301658-992E05DB-C35F-453D-BCCE-D5FC6AEE8636Q41650741-1C54D596-27C7-4675-812A-75B62CB22639Q43281151-7C62F7EC-1D88-4A07-8C34-B510CE26DED3Q43500545-76EF55DA-4632-4B0B-A7D1-CA7370D3B4B6Q44029219-CA330C77-D9B7-4C98-9294-B495A5E8E8C1Q45268861-A8440C2E-02D4-4BD3-8CBB-30AD1212379EQ46681898-81202231-8BE4-4E87-9BB9-B169C12F4279Q47306143-6D6FF59D-27BE-4FF7-B854-379C8B004634Q48122441-7D26D0EF-9D2C-49FE-B99E-458C8847B3EFQ50638104-6A4E0227-D02D-483B-B0F3-602D17EA449F
P2860
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Aspirin in the prevention of p ...... -analysis of randomised trials
@ast
Aspirin in the prevention of p ...... -analysis of randomised trials
@en
Aspirin in the prevention of p ...... -analysis of randomised trials
@nl
type
label
Aspirin in the prevention of p ...... -analysis of randomised trials
@ast
Aspirin in the prevention of p ...... -analysis of randomised trials
@en
Aspirin in the prevention of p ...... -analysis of randomised trials
@nl
prefLabel
Aspirin in the prevention of p ...... -analysis of randomised trials
@ast
Aspirin in the prevention of p ...... -analysis of randomised trials
@en
Aspirin in the prevention of p ...... -analysis of randomised trials
@nl
P2093
P2860
P50
P921
P3181
P1476
Aspirin in the prevention of p ...... -analysis of randomised trials
@en
P2093
E Hämäläinen
E Kajantie
PREDO Study group
P2860
P3181
P356
10.1111/J.1471-0528.2012.03493.X
P407
P577
2012-11-06T00:00:00Z